MedPath

Rhomicosin 20FG Oral Powder 20%w/w

Registration Number: MAL20162581HA

Approved
Approval ID

f0a850cf6dd53e02

Registration Number

MAL20162581HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Last UpdatedJul 4, 2025

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TILMICOSIN PHOSPHATEActive
Monograph: tilmicosin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rhomicosin 20FG Oral Powder 20%w/w - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform